Roche launches v-TAC blood gas digital solution
Swiss healthcare company Roche has launched a new blood gas digital solution called Roche v-TAC, which is said to be designed to enhance patient care. ... Read More
Thermo Fisher, WuXi, Mayo Clinic to develop total antibodies Covid-19 test
US life sciences company Thermo Fisher Scientific said that it will collaborate with China-based WuXi Diagnostics and Mayo Clinic to develop a total antibodies Covid-19 ... Read More
Olympic Ophthalmics gets FDA clearance for iTEAR100 Neurostimulator
US medical technology company Olympic Ophthalmics has secured clearance from the US Food and Drug Administration for its iTEAR100 Neurostimulator. iTEAR100 is an external neurostimulator ... Read More
FDA rejects Blueprint’s NDA for AYVAKIT for treatment of fourth-line GIST
Blueprint Medicines said that the US Food and Drug Administration (FDA) has rejected its new drug application (NDA) for AYVAKIT (avapritinib) for the treatment of ... Read More
FDA rejects Blueprint’s NDA for AYVAKIT for treatment of fourth-line GIST
Blueprint Medicines said that the US Food and Drug Administration (FDA) has rejected its new drug application (NDA) for AYVAKIT (avapritinib) for the treatment of ... Read More
Sorrento Therapeutics says STI-1499 fully inhibited SARS-CoV-2 virus
Sorrento Therapeutics said that STI-1499, its anti-SARS-CoV-2 antibody, showed 100% inhibition of SARS-CoV-2 virus infection in an in vitro virus infection experiment at a very ... Read More
Rohatyn Group completes investment in Croatian CRO Optimapharm
The Rohatyn Group (TRG), a US asset management firm focusing on emerging markets, has completed an investment in Optimapharm, a contract research organization (CRO) based ... Read More
Abbott gets FDA EUA for COVID-19 antibody blood test on Alinity i system
Abbott has been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its SARS-CoV-2 IgG lab-based serology blood test, a ... Read More
HKBU-led researchers develop EBV drug for nasopharyngeal cancer
A research team headed by Hong Kong Baptist University (HKBU) claims to have developed a novel anti-Epstein-Barr virus (EBV) drug for the treatment of nasopharyngeal ... Read More
AbbVie wraps up $63bn acquisition of Irish drugmaker Allergan
US biopharma company AbbVie has wrapped up its previously announced $63 billion acquisition of Irish drugmaker Allergan following receipt of all the required approvals from ... Read More